Glucocorticoids for Preventing Migraine Recurrence in the Emergency Department
This Viewpoint discusses glucocorticoid recommendations for treating migraine in the emergency department (ED), describing the potential for harm that means it should not be a reflexive first-line choice for either children or adults.
Authors
- Serena L. Orr (ORCID: https://orcid.org/0000-0002-2879-811X)
- Daniel J. Shapiro (ORCID: https://orcid.org/0000-0001-9429-1053)
- Amy A Gelfand
Institutions
- University of Calgary (CA)
- University of California, San Francisco (US)
- American Academy of Child and Adolescent Psychiatry (US)
- Alberta Children's Hospital (CA)
- Ontario Brain Institute (CA)
- Alberta Children's Hospital Research Institute
- Hotchkiss Brain Institute (CA)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1001/jamaneurol.2025.5493
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00